Decreased noradrenergic and serotonergic reactivity of vas deferens of newborn rats from mothers treated with the serotonin reuptake inhibitor fluoxetine during pregnancy and breast-feeding

Life Sciences

Volumn 81, Issue 21-22, 2007, Pages 1501-1508

  Pereira, Janaina D ^a   Caricati Neto, Afonso ^a   Jurkiewicz, Aron ^a   Jurkiewicz, Neide H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast feeding; Fluoxetine; Neurotransmission; Pregnancy; Serotonin; Vas deferens

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CLONIDINE; DOPAMINE; FLUOXETINE; NORADRENALIN; PHENYLEPHRINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TYRAMINE;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; BREAST FEEDING; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MUSCLE CONTRACTION; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PREGNANCY; RAT; SEROTONINERGIC SYSTEM; VAS DEFERENS;

ANIMALS; ANIMALS, NEWBORN; BARIUM; BIRTH WEIGHT; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; FLUOXETINE; GROWTH; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; VAS DEFERENS;

RATTUS; RATTUS NORVEGICUS;

EID: 35848951631     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.012     Document Type: Article

References (44)

1. Anbu A.T., and Theodore A. Fluoxetine withdrawal syndrome in the newborn. Indian Pediatrics 43 (2006) 66-69
2. Benfield P., Heel R.C., and Lewis S.P. Fluoxetine - a review of its pharmacodynamic and pharmacokinetic proprieties, and therapeutic efficacy in depressive illness. Drugs 32 (1986) 481-508
3. Busch L., Wald M., and Borda E. Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility. Life Sciences 64 (1999) PL117-PL126
4. Busch L., Wald M., and Sterin-Borda L. Fluoxetine modulates norepinephrine contractile effect on rat vas deferens. Pharmacological Research 41 (2000) 39-45
5. Byrd R.A., and Markham J.K. Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits. Fundamental and Applied Toxicology 22 (1994) 511-518
6. Caricati-Neto A., Pupo A.S., Wanderley A.G., Nuñez-Vergara M., Ho Jun Ko I., Jurkiewicz N.H., and Jurkiewicz A. Role of the epithelium in the release of contractile agents from the rat vas deferens by clonidine. Annals of New York Academy of Sciences 763 (1995) 436-439
7. Caricati-Neto A., D'Angelo L.C.A., Reuter H., Jurkiewicz N.H., Garcia A., and Jurkiewicz A. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. European Journal of Pharmacology 503 (2004) 191-201
8. Castillo C.F., Lafayette S., Caricati-Neto A., Sette M., Jurkiewicz N.H., Garcia A.G., and Jurkiewicz A. Low dihydropyridine receptor density in vasa deferentia of castrated rats. British Journal of Pharmacology 105 (1992) 257-258
9. Chambers C.D., Anderson P.O., Thomas R.G., Dick L.M., Felix R.J., Johnson K.A., and Jones K.L. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104 (1999) 61-66
10. Conceição I.M., Jurkiewicz A., Fonseca D.R., Opperman A.R., Freitas T.A., Lebrun I., and Carmo L.G. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-1 from Brazilian scorpion Tityus serrulatus. British Journal of Pharmacology 144 (2005) 519-527
11. Da-Silva V.A., Altenburg S.P., Malheiros L.R., Thomaz T.G., and Lindsey C.J. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Brazilian Journal of Medical and Biological Research 32 (1999) 93-98
12. El-Mas M.M., Elmallah A.I., Omar A.G., and Sharabi F. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects. Pharmacological Research 39 (1999) 11-19
13. Halford J.C., Harrold J.A., Lawton C.L., and Blundell J.E. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Current Drug Targets 6 (2005) 201-213
14. Heikkinen T., Ekblad U., Palo P., and Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clinical Pharmacology and Therapeutics 73 (2003) 330-337
15. Jurkiewicz A., and Jurkiewicz N.H. Dual effect of alpha-adrenoceptor antagonists in rat isolated vas deferens. British Journal of Pharmacology 56 (1976) 169-178
16. Jurkiewicz N.H., and Jurkiewicz A. Release of contractile agents from rat vas deferens by clonidine. Life Sciences 49 (1991) 1643-1649
17. Jurkiewicz A., Jurkiewicz N., Barros G.G., and Valle J.R. Relative responsiveness (ρ) of pharmacological receptor systems in the rat vas deferens. Pharmacology 2 (1969) 89-99
18. Jurkiewicz A., Markus R.P., and Picarelli Z.P. Effect of full agonists following calcium deprivation in rat vas deferens. European Journal of Pharmacology 31 (1975) 292-304
19. Jurkiewicz A., Abdo A.O., Jurkiewicz N.H., Guedes A.O., and Souccar C. Relative responsiveness (ρ): a critical analysis of a new method in receptor differentiation. General Pharmacology 7 (1976) 93-101
20. Jurkiewicz A., Jurkiewicz N.H., Gomes C.B., and Aucélio J.G. Pharmacodynamic analysis of the rat isolated vas deferens after transplantation to intestinal wall. Journal of Pharmacology and Experimental Therapeutics 203 (1977) 112-119
21. Jurkiewicz A., Langeloh A., and Guedes A. Time-response curves for barium and noradrenaline in vas deferens of castrated rat. European Journal of Pharmacology 45 (1977) 145-151
22. Jurkiewicz N.H., Garcia A.G., and Jurkiewicz A. In vitro denervation of the rat vas deferens through hypothermic storage. British Journal of Pharmacology 107 (1992) 610-615
23. Jurkiewicz A., Garcez do Carmo L., Yomura M.H., and Jurkiewicz N.H. The serotonin paradox: drug-receptor interaction in rat vas deferens. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana 49 (1999) 210-214
24. Kim J., Riggs K.W., Misri S., Kent N., Oberlander T.F., Grunau R.E., Fitzgerald C., and Rurak D.W. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. British Journal of Clinical Pharmacology 61 (2006) 155-163
25. Langeloh A., and Jurkiewicz A. Analysis of the effects of dopamine and noradrenaline in relation to the proposed postsynaptic dopamine receptor in rat vas deferens. Naunyn Schmiedeberg's Archives of Pharmacology 318 (1982) 202-209
26. Levinson-Castiel R., Merlob P., Linder N., Sirota L., and Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Archives of Pediatric Adolescent Medicine 160 (2006) 173-176
27. Maina G., Albert U., Salvi V., and Bogetto F. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. Journal of Clinical Psychiatry 65 (2004) 365-371
28. Medina P., Segarra G., Ballester R., Chuan P., Domenech C., Vila J.M., and Lluch S. Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology 4 (2000) 592-597
29. Moses-Kolko E.L., Bogen D., Perel J., Bregar A., Uhl K., Levin B., and Wisner K.L. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. Journal of American Medical Association 293 (2005) 2372-2383
30. Mousavizadeh K., Ghafourifar P., and Sadeghi-Nejad H. Calcium channel blocking activity of thioridazine, clomipramine and fluoxetine in isolated rat vas deferens: a relative potency measurement study. The Journal of Urology 168 (2002) 2716-2719
31. Mullins U.L., Gianutsos G., and Eison A.S. Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21 (1999) 352-357
32. Okpalaugo E.O., Garcez-do-Carmo L., Jurkiewicz N.H., and Jurkiewicz A. Contractile responses of the rat vas deferens after epithelium removal. Life Sciences 70 (2002) 2943-2951
33. 2+sensitivity. British Journal of Pharmacology 127 (1999) 740-746
34. Picarelli Z.P., Hyppolito N., and Valle J.R. Synergistic effect of 5-hydroxytryptamine on the response of rats' seminal vesicles to adrenaline and noradrenaline. Archives Internationales de Pharmacodynamie et de Thérapie 138 (1962) 354-363
35. Pullar I.A., and Findlay J.D. Effect of voltage-sensitive calcium channel antagonists on the release of 5-hydroxytryptamine from rat hippocampus in vivo. Journal of Neurochemistry 59 (1992) 553-559
36. Rampono J., Proud S., Hackett L.P., Kristensen J.H., and Ilett K.F. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. International Journal of Neuropsychopharmacology 7 (2004) 329-334
37. Sanz E.J., De-las-Cuevas C., Kiuru A., Bate A., and Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365 (2005) 482-487
38. 2+)-channel inhibition. Life Sciences 50 (1992) 2125-2138
39. Vladimirova I., Jurkiewicz N.H., and Jurkiewicz A. Evidence for participation of nitric oxide in excitatory neurotransmission in rat vas deferens. Life Sciences 55 (1994) 1123-1128
40. Vorhees C.V., Acuff-Smith K.D., Schilling M.A., Fisher J.E., Moran M.S., and Buelke-Sam J. A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundamental and Applied Toxicology 23 (1994) 194-205
41. Weissman A.M., Levy B.T., Hartz A.J., Bentler S., Danohoue M., Ellingrod V.L., and Wisner K.L. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. American Journal of Psychiatry 161 (2004) 1066-1078
42. Wong D.T., Perry K.W., and Bymaster F.P. The discovery of fluoxetine hydrochloride (prozac). Nature reviews 4 (2005) 764-774
43. Yoshida K., Smith B., Craggs M., and Kumar R.C. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. British Journal of Psychiatry 172 (1998) 175-179
44. Zajecka J., Tracy K.A., and Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. Journal of Clinical Psychiatry 58 (1997) 291-297